United States Antihypertensive Drugs Market Report 2017

October 2017 | 113 pages | ID: U1661A4A48DEN
QYResearch

Abstracts

In this report, the United States Antihypertensive Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Antihypertensive Drugs in these regions, from 2012 to 2022 (forecast).

United States Antihypertensive Drugs market competition by top manufacturers/players, with Antihypertensive Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis
• Pfizer
• Johnson & Johnson
• Sanofi
• Lupin
• Ranbaxy Laboratories
• Merck
• Astra Zeneca
• Daiichi Sankyo
• Takeda
• Actelion
• United Therapeutics

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• ARB
• CCB
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antihypertensive Drugs for each application, including

• Hypertension
• PAH
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Antihypertensive Drugs Market Report 2017

1 ANTIHYPERTENSIVE DRUGS OVERVIEW

1.1 Product Overview and Scope of Antihypertensive Drugs
1.2 Classification of Antihypertensive Drugs by Product Category
  1.2.1 United States Antihypertensive Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Antihypertensive Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 ARB
  1.2.4 CCB
  1.2.5 Other
1.3 United States Antihypertensive Drugs Market by Application/End Users
  1.3.1 United States Antihypertensive Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hypertension
  1.3.3 PAH
  1.3.4 Other
1.4 United States Antihypertensive Drugs Market by Region
  1.4.1 United States Antihypertensive Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Antihypertensive Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Antihypertensive Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Antihypertensive Drugs Status and Prospect (2012-2022)
  1.4.5 New England Antihypertensive Drugs Status and Prospect (2012-2022)
  1.4.6 The South Antihypertensive Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Antihypertensive Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Antihypertensive Drugs (2012-2022)
  1.5.1 United States Antihypertensive Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Antihypertensive Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANTIHYPERTENSIVE DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Antihypertensive Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Antihypertensive Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Antihypertensive Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Antihypertensive Drugs Market Competitive Situation and Trends
  2.4.1 United States Antihypertensive Drugs Market Concentration Rate
  2.4.2 United States Antihypertensive Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antihypertensive Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTIHYPERTENSIVE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Antihypertensive Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Antihypertensive Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Antihypertensive Drugs Price by Region (2012-2017)

4 UNITED STATES ANTIHYPERTENSIVE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Antihypertensive Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Antihypertensive Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Antihypertensive Drugs Price by Type (2012-2017)
4.4 United States Antihypertensive Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANTIHYPERTENSIVE DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Antihypertensive Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Antihypertensive Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTIHYPERTENSIVE DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antihypertensive Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.2 Antihypertensive Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson
  6.3.2 Antihypertensive Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Johnson & Johnson Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.2 Antihypertensive Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Lupin
  6.5.2 Antihypertensive Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Lupin Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Ranbaxy Laboratories
  6.6.2 Antihypertensive Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Ranbaxy Laboratories Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Merck
  6.7.2 Antihypertensive Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Merck Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Astra Zeneca
  6.8.2 Antihypertensive Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Astra Zeneca Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Daiichi Sankyo
  6.9.2 Antihypertensive Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Daiichi Sankyo Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Takeda
  6.10.2 Antihypertensive Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Takeda Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Actelion
6.12 United Therapeutics

7 ANTIHYPERTENSIVE DRUGS MANUFACTURING COST ANALYSIS

7.1 Antihypertensive Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antihypertensive Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antihypertensive Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antihypertensive Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTIHYPERTENSIVE DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Antihypertensive Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Antihypertensive Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Antihypertensive Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Antihypertensive Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antihypertensive Drugs
Figure United States Antihypertensive Drugs Market Size (K MT) by Type (2012-2022)
Figure United States Antihypertensive Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure ARB Product Picture
Figure CCB Product Picture
Figure Other Product Picture
Figure United States Antihypertensive Drugs Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Antihypertensive Drugs by Application in 2016
Figure Hypertension Examples
Table Key Downstream Customer in Hypertension
Figure PAH Examples
Table Key Downstream Customer in PAH
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Antihypertensive Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Antihypertensive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Antihypertensive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Antihypertensive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Antihypertensive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Antihypertensive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Antihypertensive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antihypertensive Drugs Sales (K MT) and Growth Rate (2012-2022)
Figure United States Antihypertensive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antihypertensive Drugs Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Antihypertensive Drugs Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Antihypertensive Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antihypertensive Drugs Sales Share by Players/Suppliers
Figure 2017 United States Antihypertensive Drugs Sales Share by Players/Suppliers
Figure United States Antihypertensive Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Antihypertensive Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Antihypertensive Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antihypertensive Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Antihypertensive Drugs Revenue Share by Players/Suppliers
Table United States Market Antihypertensive Drugs Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Antihypertensive Drugs Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Antihypertensive Drugs Market Share of Top 3 Players/Suppliers
Figure United States Antihypertensive Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antihypertensive Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antihypertensive Drugs Product Category
Table United States Antihypertensive Drugs Sales (K MT) by Region (2012-2017)
Table United States Antihypertensive Drugs Sales Share by Region (2012-2017)
Figure United States Antihypertensive Drugs Sales Share by Region (2012-2017)
Figure United States Antihypertensive Drugs Sales Market Share by Region in 2016
Table United States Antihypertensive Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Antihypertensive Drugs Revenue Share by Region (2012-2017)
Figure United States Antihypertensive Drugs Revenue Market Share by Region (2012-2017)
Figure United States Antihypertensive Drugs Revenue Market Share by Region in 2016
Table United States Antihypertensive Drugs Price (USD/MT) by Region (2012-2017)
Table United States Antihypertensive Drugs Sales (K MT) by Type (2012-2017)
Table United States Antihypertensive Drugs Sales Share by Type (2012-2017)
Figure United States Antihypertensive Drugs Sales Share by Type (2012-2017)
Figure United States Antihypertensive Drugs Sales Market Share by Type in 2016
Table United States Antihypertensive Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Antihypertensive Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antihypertensive Drugs by Type (2012-2017)
Figure Revenue Market Share of Antihypertensive Drugs by Type in 2016
Table United States Antihypertensive Drugs Price (USD/MT) by Types (2012-2017)
Figure United States Antihypertensive Drugs Sales Growth Rate by Type (2012-2017)
Table United States Antihypertensive Drugs Sales (K MT) by Application (2012-2017)
Table United States Antihypertensive Drugs Sales Market Share by Application (2012-2017)
Figure United States Antihypertensive Drugs Sales Market Share by Application (2012-2017)
Figure United States Antihypertensive Drugs Sales Market Share by Application in 2016
Table United States Antihypertensive Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Antihypertensive Drugs Sales Growth Rate by Application (2012-2017)
Table Novartis Basic Information List
Table Novartis Antihypertensive Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Antihypertensive Drugs Sales Growth Rate (2012-2017)
Figure Novartis Antihypertensive Drugs Sales Market Share in United States (2012-2017)
Figure Novartis Antihypertensive Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Antihypertensive Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Antihypertensive Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Antihypertensive Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Antihypertensive Drugs Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Antihypertensive Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Antihypertensive Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Antihypertensive Drugs Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Antihypertensive Drugs Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Antihypertensive Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Antihypertensive Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Antihypertensive Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi Antihypertensive Drugs Revenue Market Share in United States (2012-2017)
Table Lupin Basic Information List
Table Lupin Antihypertensive Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Lupin Antihypertensive Drugs Sales Growth Rate (2012-2017)
Figure Lupin Antihypertensive Drugs Sales Market Share in United States (2012-2017)
Figure Lupin Antihypertensive Drugs Revenue Market Share in United States (2012-2017)
Table Ranbaxy Laboratories Basic Information List
Table Ranbaxy Laboratories Antihypertensive Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Ranbaxy Laboratories Antihypertensive Drugs Sales Growth Rate (2012-2017)
Figure Ranbaxy Laboratories Antihypertensive Drugs Sales Market Share in United States (2012-2017)
Figure Ranbaxy Laboratories Antihypertensive Drugs Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Antihypertensive Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck Antihypertensive Drugs Sales Growth Rate (2012-2017)
Figure Merck Antihypertensive Drugs Sales Market Share in United States (2012-2017)
Figure Merck Antihypertensive Drugs Revenue Market Share in United States (2012-2017)
Table Astra Zeneca Basic Information List
Table Astra Zeneca Antihypertensive Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Astra Zeneca Antihypertensive Drugs Sales Growth Rate (2012-2017)
Figure Astra Zeneca Antihypertensive Drugs Sales Market Share in United States (2012-2017)
Figure Astra Zeneca Antihypertensive Drugs Revenue Market Share in United States (2012-2017)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Antihypertensive Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Daiichi Sankyo Antihypertensive Drugs Sales Growth Rate (2012-2017)
Figure Daiichi Sankyo Antihypertensive Drugs Sales Market Share in United States (2012-2017)
Figure Daiichi Sankyo Antihypertensive Drugs Revenue Market Share in United States (2012-2017)
Table Takeda Basic Information List
Table Takeda Antihypertensive Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Takeda Antihypertensive Drugs Sales Growth Rate (2012-2017)
Figure Takeda Antihypertensive Drugs Sales Market Share in United States (2012-2017)
Figure Takeda Antihypertensive Drugs Revenue Market Share in United States (2012-2017)
Table Actelion Basic Information List
Table United Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antihypertensive Drugs
Figure Manufacturing Process Analysis of Antihypertensive Drugs
Figure Antihypertensive Drugs Industrial Chain Analysis
Table Raw Materials Sources of Antihypertensive Drugs Major Players/Suppliers in 2016
Table Major Buyers of Antihypertensive Drugs
Table Distributors/Traders List
Figure United States Antihypertensive Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Antihypertensive Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Antihypertensive Drugs Price (USD/MT) Trend Forecast (2017-2022)
Table United States Antihypertensive Drugs Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Antihypertensive Drugs Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Antihypertensive Drugs Sales Volume (K MT) Forecast by Type in 2022
Table United States Antihypertensive Drugs Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Antihypertensive Drugs Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Antihypertensive Drugs Sales Volume (K MT) Forecast by Application in 2022
Table United States Antihypertensive Drugs Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Antihypertensive Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antihypertensive Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antihypertensive Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources